Biovotion
Clinical-grade vital sign monitoring
Zurich, Switzerland
Acquired for its wearable biosensor capabilities.
How We Help
Problem Statement
To solve the problem of fragmented healthcare data and the lack of reliable, continuous physiological monitoring outside of clinical settings by providing medical-grade wearable devices.
Core Technology
Multi-sensor wearable platform for continuous, real-time physiological monitoring.
Key Differentiators
Medical-grade wearable sensing technology; Combines connected hardware with data analytics and monitoring services; Generates personalized and predictive health insights from continuous vital sign data
Clinical Focus
Physiological Monitoring
Company Info
- Business Model
- Hybrid
- Total Funding
- 13,400,000
- Website
- www.biovotion.com
Categories
Technologies
Clinical & IP
Clinical Validation
Heart rate and SpO2 clinically validated. Published clinical validation study on surgical wards. Part of Biofourmis Biovitals® ecosystem with 70% reduction in 30-day readmissions.
MedStartr Index Score
?What do you think of Biovotion?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.